CSM Advisors LLC Makes New Investment in Intuitive Surgical, Inc. $ISRG

Key Points

• CSM Advisors LLC bought a new stake of 3,357 shares of Intuitive Surgical in Q3, valued at about $1,503,000.
• Intuitive Surgical recently beat quarterly estimates with EPS of $2.53 vs. $2.27 and revenue of $2.87B (up 18.8% YoY); the stock has a market cap of $171.69B and a MarketBeat consensus of “Moderate Buy” with an average target of $615.86.
• Insiders sold 32,943 shares worth $17.28M over the last quarter, while company insiders own 0.70% and institutional investors hold 83.64% of the stock.

CSM Advisors LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund bought 3,357 shares of the medical equipment provider's stock, valued at approximately $1,503,000.

A number of other large investors also recently made changes to their positions in ISRG. Kilter Group LLC bought a new stake in Intuitive Surgical in the second quarter valued at about $27,000. Greykasell Wealth Strategies Inc. bought a new position in Intuitive Surgical during the third quarter worth about $27,000. Caitlin John LLC bought a new position in Intuitive Surgical during the third quarter worth about $30,000. Guerra Advisors Inc acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth about $37,000. Finally, Riggs Asset Managment Co. Inc. grew its position in shares of Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider's stock worth $38,000 after buying an additional 32 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 105 shares of the company's stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 32,943 shares of company stock worth $17,279,568. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Up 2.4%

Shares of ISRG stock opened at $483.46 on Tuesday. The firm has a fifty day moving average of $511.60 and a 200-day moving average of $513.03. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The company has a market capitalization of $171.69 billion, a price-to-earnings ratio of 61.28, a P/E/G ratio of 3.64 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion for the quarter, compared to analysts' expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm's revenue was up 18.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.21 EPS. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on ISRG. HSBC upped their price target on Intuitive Surgical from $644.00 to $653.00 and gave the company a "buy" rating in a research note on Monday, January 26th. Raymond James Financial boosted their price objective on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an "outperform" rating in a report on Friday, January 23rd. TD Cowen raised shares of Intuitive Surgical to a "strong-buy" rating in a research note on Tuesday, January 27th. UBS Group set a $570.00 target price on shares of Intuitive Surgical and gave the stock a "neutral" rating in a report on Tuesday, February 24th. Finally, BTIG Research reissued a "buy" rating and set a $616.00 price target on shares of Intuitive Surgical in a research report on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $615.86.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.